XML 98 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
Information by segment and main country - Reconciliation from net income to Adjusted EBITA (Detail) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Information by segment and main country [Line Items]      
Profit (loss) [1] € 3,323 [2],[3] € 1,195 [3],[4] € 1,173 [4]
Profit (loss) from discontinued operations [1] 2,711 [2],[3] 196 [4],[5] 183 [4],[5]
Tax expense (income) [4] (103) 212 258
Share of profit (loss) of associates and joint ventures accounted for using equity method [4] (4) (9) 1
Finance costs [4] 188 202 233
Finance income [4] 149 158 114
Profit (loss) from operating activities [4] 553 1,264 1,366
Amortization of acquired intangible assets [4] 322 [3] 377 [3] 344
Impairment loss recognised in profit or loss, goodwill 15 [2],[3] 144 [3],[4] 97 [4]
Earnings before interest, taxes and amortization [4] 890 1,784 1,807
Restructuring and acquisition-related charges 95 [2],[3] 195 [3],[4] 310 [4]
Other items 1,069 [2],[3] 299 [3],[4] 153 [4]
Adjusted EBITA [4] 2,054 2,277 2,270
Diagnosis & Treatment [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities [4] 941 497 660
Amortization of acquired intangible assets [4] 153 209 177
Impairment loss recognised in profit or loss, goodwill [4] 2 0 19
Earnings before interest, taxes and amortization [4] 1,097 706 856
Restructuring and acquisition-related charges [4] 7 29 149
Other items [4] (32) 83 73
Adjusted EBITA [4] 1,071 [6] 818 1,078
Connected Care [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities [4] (732) 711 269
Amortization of acquired intangible assets [4] 148 134 141
Impairment loss recognised in profit or loss, goodwill [4] 13 144 78
Earnings before interest, taxes and amortization [4] (571) 989 488
Restructuring and acquisition-related charges [4] 93 97 64
Other items [4] 965 112 67
Adjusted EBITA [4] 488 1,198 620
Personal Health [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities [4] 585 356 589
Amortization of acquired intangible assets [4] 15 16 18
Earnings before interest, taxes and amortization [4] 600 371 607
Restructuring and acquisition-related charges [4] (1) 31 42
Other items [4] 0 24 23
Adjusted EBITA [4] 599 426 672
Other [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities [4] (242) (300) (152)
Amortization of acquired intangible assets [4] 6 18 8
Earnings before interest, taxes and amortization [4] (236) (282) (144)
Restructuring and acquisition-related charges [4] (5) 37 54
Other items [4] 136 81 (11)
Adjusted EBITA [4] € (105) € (165) € (100)
[1] For a number of reasons, principally the effects of translation differences and consolidation changes, certain items in the statements of cash flows do not correspond to the differences between the balance sheet amounts for the respective items in the accompanying notes of the consolidated financial statements.
[2] Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.
[3] Shareholders in this table refers to shareholders of Koninklijke Philips N.V.
[4] Non-IFRS financial measure. For the definition and reconciliation of the most directly comparable IFRS measure, refer to Reconciliation of non-IFRS information.
[5] Shareholders in this table refers to shareholders of Koninklijke Philips N.V.
[6] In 2019 Philips’ Emerging Businesses were moved out of segment Other into segment Diagnosis & Treatment to enable these businesses with better access to downstream capabilities. While these businesses remain in (semi-)incubator phase, in 2021 they received a corporate funding out of segment Other of EUR 16 million (2020: EUR 38 million, 2019: EUR 54 million) to support them during their emerging idea-to-market business phase.